Search

Author/Creator Lyle, Megan

1. Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors. Issue 21 (28th July 2015)

Authors:
Menzies, Alexander M.; Wilmott, James S.; Drummond, Martin; Lo, Serigne; Lyle, Megan; Chan, Matthew M. K.; Thompson, John F.; Guminski, Alex; Carlino, Matteo S.; Scolyer, Richard A.; Kefford, Richard F.; Long, Georgina V.
Journal:
Cancer
Issue:
Volume 121:Issue 21(2015)
Page Start:
3826
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation. (April 2023)

Authors:
Weppler, Alison M.; Da Meda, Laetitia; Pires da Silva, Ines; Xu, Wen; Grignani, Giovanni; Menzies, Alexander M.; Carlino, Matteo S.; Long, Georgina V.; Lo, Serigne N.; Nordman, Ina; Steer, Christopher B.; Lyle, Megan; Trojaniello, Claudia; Ascierto, Paolo A.; Lebbe, Celeste; Sandhu, Shahneen
Journal:
European journal of cancer
Issue:
Volume 183(2023)
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. Issue 6 (June 2021)

Authors:
Pires da Silva, Ines; Ahmed, Tasnia; Reijers, Irene L M; Weppler, Alison M; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Trojaniello, Claudia; Stout, Dan; Lyle, Megan; Klein, Oliver; Gerard, Camille L; Mic...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
836
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Metastasis‐specific patterns of response and progression with anti‐PD‐1 treatment in metastatic melanoma. (7th December 2017)

Authors:
Lee, Jenny H. J.; Lyle, Megan; Menzies, Alexander M.; Chan, Matthew M. K.; Lo, Serigne; Clements, Arthur; Carlino, Matteo S.; Kefford, Richard F.; Long, Georgina V.
Journal:
Pigment cell & melanoma research
Issue:
Volume 31:Number 3(2018)
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy. (August 2021)

Authors:
Hepner, Adriana; Atkinson, Victoria G.; Larkin, James; Burrell, Rebecca A.; Carlino, Matteo S.; Johnson, Douglas B.; Zimmer, Lisa; Tsai, Katy K.; Klein, Oliver; Lo, Serigne N.; Haydon, Andrew; Bhave, Prachi; Lyle, Megan; Pallan, Lalit; Pires da Silva, Ines; Gerard, Camille; Michielin, Olivier; Lo...
Journal:
European journal of cancer
Issue:
Volume 153(2021)
Page Start:
213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition. Issue 20 (1st July 2014)

Authors:
Chan, Matthew M. K.; Haydu, Lauren E.; Menzies, Alexander M.; Azer, Mary W. F.; Klein, Oliver; Lyle, Megan; Clements, Arthur; Guminski, Alexander; Kefford, Richard F.; Long, Georgina V.
Journal:
Cancer
Issue:
Volume 120:Issue 20(2014)
Page Start:
3142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition. Issue 20 (1st July 2014)

Authors:
Chan, Matthew M. K.; Haydu, Lauren E.; Menzies, Alexander M.; Azer, Mary W. F.; Klein, Oliver; Lyle, Megan; Clements, Arthur; Guminski, Alexander; Kefford, Richard F.; Long, Georgina V.
Journal:
Cancer
Issue:
Volume 120:Issue 20(2014)
Page Start:
3142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗